Log In
BCIQ
Print this Print this
 

liprotamase (Sollpura) (LY3031642)

Also known as: Solpura, Trizytek (TheraCLEC) (formerly ALTU-135)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionNon-porcine, soluble and stable mixture of cross-linked crystalline lipase, crystalline protease and amorphous amylase
Molecular Target Not available
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase III
Standard IndicationPancreatic insufficiency
Indication DetailsTreat exocrine pancreatic insufficiency (EPI); Treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF); Treat malabsorption due to exocrine pancreatic insufficiency (EPI) in chronic pancreatitis patients; Treat malabsorption due to exocrine pancreatic insufficiency (EPI) in cystic fibrosis (CF) patients; Treat malabsorption due to pancreatic insufficiency
Regulatory Designation U.S. - Undisclosed Review (Treat exocrine pancreatic insufficiency (EPI))
PartnerAnthera Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$380.0M

$180.0M

$200.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today